Ronald Todd Plott, Director at Phio Pharmaceuticals Corp. (PHIO), bought 15,000 shares at $1.14 ($17K) on 2026-08-19, disclosed to the SEC on 2026-08-20.
Director Ronald Todd Plott purchased $17,100 worth of shares at $1.14, marking the largest insider purchase in the company's history. This significant accumulation suggests insider confidence in the company's long-term value proposition, particularly following recent intellectual property milestones.
The stock has rallied 6.02% over the past five days and is currently trading 6.91% below its 52-week high of $1.23, while remaining 35.44% above the 52-week low of $0.8454.
Nothing distinguishes this filing.